Inari Medical, Inc.
NARIDelisted Feb 19, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001531048
Inari Medical, Inc. was delisted on Feb 19, 2025; its insiders filed their last Form 4 on Feb 19, 2025; 258 institutions reported holding it in 13F filings for Q4 2024, worth $2.80B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Inari Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Inari Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mead Dana G Jr. | Director | 0 | Feb 19, 2025 | 0 |
| Root Jonathan D | Director | 0Indirect | Feb 19, 2025 | 0 |
| Milder Donald B | Director | 0Indirect | Feb 19, 2025 | 0 |
| Hoffman William | Director | 0 | Feb 19, 2025 | 0 |
| Lucchese Cynthia L | Director | 0 | Feb 19, 2025 | 0 |
| Szyman Catherine M. | Director | 0 | Feb 19, 2025 | 0 |
| Tu Thomas | Chief Medical Officer | 0 | Feb 19, 2025 | 0 |
| Hykes Andrew | President and CEO | 0 | Feb 19, 2025 | 0 |
| Chambers Rebecca | Director | 0 | Feb 19, 2025 | 0 |
| Warner Robert Keith | Director | 0 | Feb 19, 2025 | 0 |
| Strange Kevin T | Chief Financial Officer | 0 | Feb 19, 2025 | 0 |
| Silva Karen | Principal Accounting Officer | 0 | Feb 19, 2025 | 0 |
| Hill, Mitch C. | Chief Financial Officer | 177,533 | Oct 2, 2024 | 0 |
| Nielsen Kirk G. | Director | 61,479 | May 30, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 (view filing)1:35 PM ET | Aug 9 | 1 day | Hill, Mitch C.Chief Financial Officer | SSale | −5.00K | $95.16 | −$475.8K | −6.9%67.9K after | 3 lots |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Hoffman WilliamPresident and CEO | SSale | −30.0K | $93.33 | −$2.80M | −3.9%730.8K after | 3 lots |
| Jul 28, 2021 (view filing)1:28 PM ET | Jul 27 | 1 day | Tu ThomasChief Medical Officer | SSale | −5.00K | $84.20 | −$421.0K | −9.3%48.9K after | 4 lots |
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Hykes AndrewChief Operating Officer | SSale | −9.00K | $85.21 | −$766.9K | −4.6%187.2K after | 4 lots |
| Jul 12, 2021 (view filing)7:44 PM ET | Jul 9 | 3 days | Hill, Mitch C.Chief Financial Officer | SSale | −5.00K | $92.71 | −$463.5K | −6.9%67.7K after | 4 lots |
| Jul 12, 2021 (view filing) | Jul 9 | 3 days | Milder Donald BDirector, 10% Owner | SSale | −7.00K | $92.72 | −$649.0K | −0.2%4.56M after | 4 lots |
| Jul 7, 2021 (view filing) | Jul 7 | Same day | Hoffman WilliamPresident and CEO | SSale | −69.9K | $91.48 | −$6.40M | −8.4%760.6K after | 6 lots |
| Jul 7, 2021 (view filing) | Jul 6 | 1 day | Hoffman WilliamPresident and CEO | SSale | −60.1K | $94.22 | −$5.66M | −6.7%831.0K after | 5 lots |